Literature DB >> 15893733

Human CD69 associates with an N-terminal fragment of calreticulin at the cell surface.

Barbara A Vance1, Patricia H Harley, Peter S Backlund, Yvona Ward, Tracy L Phelps, Ronald E Gress.   

Abstract

CD69 is thought to be a pluripotent signaling molecule expressed on the surface of a number of activated leukocytes including B, T, and NK cells, monocytes, neutrophils, and platelets. While some advances have been made regarding the mechanisms by which CD69 may participate in such diverse functions as cell aggregation, cellular cytotoxicity, and release of cytokines and inflammatory mediators, the most proximal links of signal initiation have not been identified. Our study has identified, by immunoprecipitation and direct protein sequencing (LC/MS/MS), binding of CD69 to an N-terminal protein fragment of calreticulin expressed on the cell surface of human PBMCs. Given the recently identified roles calreticulin plays in cell adhesion and angiogensis, the identification of CD69 binding directly to calreticulin may provide insights into mechanism(s) by which CD69 or other CD69 family members, i.e., LLT1 and AICL participates in such diverse functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15893733     DOI: 10.1016/j.abb.2005.04.009

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  8 in total

1.  DC-SIGN, C1q, and gC1qR form a trimolecular receptor complex on the surface of monocyte-derived immature dendritic cells.

Authors:  Kinga K Hosszu; Alisa Valentino; Uma Vinayagasundaram; Rama Vinayagasundaram; M Gordon Joyce; Yan Ji; Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Blood       Date:  2012-06-13       Impact factor: 22.113

2.  Expression of activated molecules on CD5(+)B lymphocytes in autoimmune hemolytic anemia.

Authors:  Hongli Zhu; Wenyan Xu; Hong Liu; Huaquan Wang; Rong Fu; Yuhong Wu; Wen Qu; Guojin Wang; Jing Guan; Jia Song; Limin Xing; Zonghong Shao
Journal:  Int J Hematol       Date:  2016-03-11       Impact factor: 2.490

3.  Anti-CD69 monoclonal antibody treatment inhibits airway inflammation in a mouse model of asthma.

Authors:  Hui-ying Wang; Yu Dai; Jiao-li Wang; Xu-yan Yang; Xin-guo Jiang
Journal:  J Zhejiang Univ Sci B       Date:  2015-07       Impact factor: 3.066

Review 4.  Calreticulin: non-endoplasmic reticulum functions in physiology and disease.

Authors:  Leslie I Gold; Paul Eggleton; Mariya T Sweetwyne; Lauren B Van Duyn; Matthew R Greives; Sara-Megumi Naylor; Marek Michalak; Joanne E Murphy-Ullrich
Journal:  FASEB J       Date:  2009-11-25       Impact factor: 5.191

5.  Cellular immune response to an engineered cell-based tumor vaccine at the vaccination site.

Authors:  Qiang Zhou; Bryon D Johnson; Rimas J Orentas
Journal:  Cell Immunol       Date:  2007-06-01       Impact factor: 4.868

6.  Ketamine induces apoptosis in lung adenocarcinoma cells by regulating the expression of CD69.

Authors:  Xuhui Zhou; Peihong Zhang; Wei Luo; Lei Zhang; Rong Hu; Yu Sun; Hong Jiang
Journal:  Cancer Med       Date:  2018-02-17       Impact factor: 4.452

Review 7.  SLE: Novel Postulates for Therapeutic Options.

Authors:  Kinga K Hosszu; Alisa Valentino; Ellinor I Peerschke; Berhane Ghebrehiwet
Journal:  Front Immunol       Date:  2020-10-07       Impact factor: 7.561

8.  Epigenetic inactivation of IRX4 is responsible for acceleration of cell growth in human pancreatic cancer.

Authors:  Kanchan Chakma; Zhaodi Gu; Yakefujiang Abudurexiti; Tatsuo Hata; Fuyuhiko Motoi; Michiaki Unno; Akira Horii; Shinichi Fukushige
Journal:  Cancer Sci       Date:  2020-10-14       Impact factor: 6.716

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.